BioCentury
ARTICLE | Company News

Cubist, Optimer deal

August 5, 2013 7:00 AM UTC

Cubist will acquire partner Optimer in a cash and contingent value right (CVR) deal worth up to $801 million. Optimer shareholders will receive $10.75 in cash, which Cubist and Optimer said values the...